NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The International Myeloma Foundation (IMF) today announced plans to establish a research partnership between IMF chairman Brian G.M. Durie, M.D.; Luc Montagnier, M.D., co-recipient of the 2008 Nobel Prize in medicine; and Howard Urnovitz, Ph.D., CEO of Chronix Biomedical. The collaboration will study cancers that affect the immune system including multiple myeloma, a cancer of cells in the bone marrow. The partnership will build on Dr. Montagnier’s pioneering work with HIV; both AIDS and myeloma involve white blood cells in the immune system, and to date cannot be cured. Dr. Urnovitz studies genetic changes that take place over the course of a disease and uses the findings to aid in the diagnosis of cancer.
